Use of mHealth to support patients with TB quit smoking significantly improves smoking cessation outcomes compared with usual ...

The first health-related quality-of-life questionnaire for adolescents and young adults with cancer has been developed.

HSSIB and RCEM share widespread concern about normalising ‘corridor care’ and its impact on patients and staff across all ...

Dr Andreas Weinberger Rosen and Prof Ismail Gögenur discuss their AI-supported decision system for perioperative colorectal ...

Exposure to extreme temperatures account for 3% of NHS healthcare costs in England, equal to £3bn, which is more than its ...

Professor Thomas F. Lüscher discusses the new ESC clinical consensus statement on vaccination and its pivotal role in ...

A new analysis highlights differential long-term drug survival of commonly used biologics in psoriasis to guide treatment ...

Associate Professor Viktoria Eleftheriadou discusses the launch of the UK’s first vitiligo registry as part of the VIRTUAL-UK pilot study.

Moving medical supplies via drone was once a farfetched idea, but there are now multiple projects working to make it a reality. Kathy Oxtoby considers five case studies from the UK and the Netherlands ...

A personalised exercise and self-management rehabilitation programme for adults living with multimorbidity is both acceptable and deliverable, according to a feasibility study, paving the way for ...

Serum immunoglobulin A (IgA) is a reliable biomarker of prior respiratory syncytial virus (RSV) infection in children under two years of age, a multinational study has confirmed. Human RSV is a highly ...

The cystic fibrosis (CF) medication ivacaftor (brand name Kalydeco) is safe and effective in infants aged four weeks and over, paving the way for earlier initiation of therapy for newborns diagnosed ...